Skip to main content
Top
Published in: International Urology and Nephrology 8/2015

01-08-2015 | Nephrology - Review

Crescentic glomerulonephritis and membranous nephropathy: a rare coexistence

Authors: Olga Balafa, Rigas Kalaitzidis, Georgios Liapis, Sofia Xiromeriti, Fotios Zarzoulas, Georgios Baltatzis, Moses Elisaf

Published in: International Urology and Nephrology | Issue 8/2015

Login to get access

Abstract

Background

The coexistence of crescents and membranous glomerulonephritis (MGN) is a special characteristic in lupus nephritis. In the absence of the characteristic histological features of lupus nephritis, MGN with crescents should raise the possibility of two other histopathological entities: anti-GBM disease and necrotizing and crescentic glomerulonephritis. The last one includes patients with positive ANCA serology or not.

Results and conclusions

Here, we describe a case of a male patient who presented with extrarenal vasculitis symptoms, acute renal failure, hematuria and nephrotic-range proteinuria. ANCA serology was positive, and the biopsy revealed crescentic vasculitis plus membranous nephropathy. Reviewing the whole literature about similar histological cases, we included 38 cases with ANCA-positive serology and 30 ones with no ANCA in serum. It seems that in the first category vasculitis symptoms predominate, while in the second one these symptoms are absent. Their histological features have no major differences. In any case, the clinical course of these patients is serious, and in most cases, immunosuppression is essential in order to avoid end-stage renal disease.
Literature
2.
go back to reference Beck LH Jr, Salant DJ (2010) Membranous nephropathy: recent travels and new roads ahead. Kidney Int 77(9):765–770PubMedCrossRef Beck LH Jr, Salant DJ (2010) Membranous nephropathy: recent travels and new roads ahead. Kidney Int 77(9):765–770PubMedCrossRef
3.
go back to reference Walsh M et al (2011) Plasma exchange for renal vasculitis and idiopathic rapidly progressive glomerulonephritis: a meta-analysis. Am J Kidney Dis 57(4):566–574PubMedCentralPubMedCrossRef Walsh M et al (2011) Plasma exchange for renal vasculitis and idiopathic rapidly progressive glomerulonephritis: a meta-analysis. Am J Kidney Dis 57(4):566–574PubMedCentralPubMedCrossRef
4.
5.
go back to reference Surindran S et al (2012) Coexistence of ANCA-associated glomerulonephritis and anti-phospholipase A(2) receptor antibody-positive membranous nephropathy. Clin Kidney J 5(2):162–165PubMedCentralPubMedCrossRef Surindran S et al (2012) Coexistence of ANCA-associated glomerulonephritis and anti-phospholipase A(2) receptor antibody-positive membranous nephropathy. Clin Kidney J 5(2):162–165PubMedCentralPubMedCrossRef
6.
go back to reference Watanabe S et al (2011) Case of MPO-ANCA-associated vasculitis with membranous nephropathy. Nihon Jinzo Gakkai Shi 53(1):46–52PubMed Watanabe S et al (2011) Case of MPO-ANCA-associated vasculitis with membranous nephropathy. Nihon Jinzo Gakkai Shi 53(1):46–52PubMed
7.
go back to reference Kanahara K et al (1997) Myeloperoxidase-antineutrophil cytoplasmic antibody-associated glomerulonephritis with membranous nephropathy in remission. Intern Med 36(11):841–846PubMedCrossRef Kanahara K et al (1997) Myeloperoxidase-antineutrophil cytoplasmic antibody-associated glomerulonephritis with membranous nephropathy in remission. Intern Med 36(11):841–846PubMedCrossRef
8.
go back to reference Barrett CM et al (2014) Membranous glomerulonephritis with crescents. Int Urol Nephrol 46(5):963–971PubMedCrossRef Barrett CM et al (2014) Membranous glomerulonephritis with crescents. Int Urol Nephrol 46(5):963–971PubMedCrossRef
9.
go back to reference Shimada M et al (2013) A case of myeloperoxidase anti-neutrophil cytoplasmic antibody (MPO-ANCA)-associated glomerulonephritis and concurrent membranous nephropathy. BMC Nephrol 14:73PubMedCentralPubMedCrossRef Shimada M et al (2013) A case of myeloperoxidase anti-neutrophil cytoplasmic antibody (MPO-ANCA)-associated glomerulonephritis and concurrent membranous nephropathy. BMC Nephrol 14:73PubMedCentralPubMedCrossRef
10.
go back to reference Hu ZJ et al (2014) A case of membranous nephropathy and myeloperoxidase anti-neutrophil cytoplasmic antibody-associated glomerulonephritis. Exp Ther Med 8(4):1170–1172PubMedCentralPubMed Hu ZJ et al (2014) A case of membranous nephropathy and myeloperoxidase anti-neutrophil cytoplasmic antibody-associated glomerulonephritis. Exp Ther Med 8(4):1170–1172PubMedCentralPubMed
11.
go back to reference Dwyer KM et al (2001) Membranous nephropathy and anti-neutrophil cytoplasmic antibody-associated glomerulonephritis: a report of 2 cases. Clin Nephrol 56(5):394–397PubMed Dwyer KM et al (2001) Membranous nephropathy and anti-neutrophil cytoplasmic antibody-associated glomerulonephritis: a report of 2 cases. Clin Nephrol 56(5):394–397PubMed
12.
go back to reference Gaber LW, Wall BM, Cooke CR (1993) Coexistence of anti-neutrophil cytoplasmic antibody-associated glomerulonephritis and membranous glomerulopathy. Am J Clin Pathol 99(2):211–215PubMed Gaber LW, Wall BM, Cooke CR (1993) Coexistence of anti-neutrophil cytoplasmic antibody-associated glomerulonephritis and membranous glomerulopathy. Am J Clin Pathol 99(2):211–215PubMed
13.
go back to reference Taniguchi Y et al (1999) Myeloperoxidase antineutrophil cytoplasmic antibody-positive necrotizing crescentic glomerulonephritis and membranous glomerulonephropathy. Clin Nephrol 52(4):253–255PubMed Taniguchi Y et al (1999) Myeloperoxidase antineutrophil cytoplasmic antibody-positive necrotizing crescentic glomerulonephritis and membranous glomerulonephropathy. Clin Nephrol 52(4):253–255PubMed
14.
go back to reference Matsumoto K (2009) MPO-ANCA crescentic glomerulonephritis complicated by membranous nephropathy: MPO demonstrated in epimembranous deposits. NDT Plus 2:461–465PubMedCentralPubMed Matsumoto K (2009) MPO-ANCA crescentic glomerulonephritis complicated by membranous nephropathy: MPO demonstrated in epimembranous deposits. NDT Plus 2:461–465PubMedCentralPubMed
15.
go back to reference Nasr SH et al (2009) Membranous glomerulonephritis with ANCA-associated necrotizing and crescentic glomerulonephritis. Clin J Am Soc Nephrol 4(2):299–308PubMedCentralPubMedCrossRef Nasr SH et al (2009) Membranous glomerulonephritis with ANCA-associated necrotizing and crescentic glomerulonephritis. Clin J Am Soc Nephrol 4(2):299–308PubMedCentralPubMedCrossRef
16.
go back to reference Thajudeen B et al (2014) Membranous nephropathy with crescents in a patient with Hashimoto’s thyroiditis: a case report. Medicine (Baltimore) 93(8):e63CrossRef Thajudeen B et al (2014) Membranous nephropathy with crescents in a patient with Hashimoto’s thyroiditis: a case report. Medicine (Baltimore) 93(8):e63CrossRef
17.
go back to reference Tse WY et al (1997) Association of vasculitic glomerulonephritis with membranous nephropathy: a report of 10 cases. Nephrol Dial Transplant 12(5):1017–1027PubMedCrossRef Tse WY et al (1997) Association of vasculitic glomerulonephritis with membranous nephropathy: a report of 10 cases. Nephrol Dial Transplant 12(5):1017–1027PubMedCrossRef
18.
go back to reference Suwabe T et al (2005) Membranous glomerulopathy induced by myeloperoxidase-anti-neutrophil cytoplasmic antibody-related crescentic glomerulonephritis. Intern Med 44(8):853–858PubMedCrossRef Suwabe T et al (2005) Membranous glomerulopathy induced by myeloperoxidase-anti-neutrophil cytoplasmic antibody-related crescentic glomerulonephritis. Intern Med 44(8):853–858PubMedCrossRef
20.
go back to reference Unver S et al (2008) A rare complication of idiopathic membranous nephropathy: crescentic transformation. Ren Fail 30(5):573–575PubMedCrossRef Unver S et al (2008) A rare complication of idiopathic membranous nephropathy: crescentic transformation. Ren Fail 30(5):573–575PubMedCrossRef
21.
go back to reference Gadonski G et al (2010) Rapidly deteriorating kidney function in a young man previously diagnosed with membranous nephropathy. Nephron Clin Pract 115(2):c100–c106PubMedCentralPubMedCrossRef Gadonski G et al (2010) Rapidly deteriorating kidney function in a young man previously diagnosed with membranous nephropathy. Nephron Clin Pract 115(2):c100–c106PubMedCentralPubMedCrossRef
22.
go back to reference Rodriguez EF et al (2014) Membranous nephropathy with crescents: a series of 19 cases. Am J Kidney Dis 64(1):66–73PubMedCrossRef Rodriguez EF et al (2014) Membranous nephropathy with crescents: a series of 19 cases. Am J Kidney Dis 64(1):66–73PubMedCrossRef
23.
go back to reference James SH et al (1995) Acute renal failure in membranous glomerulonephropathy: a result of superimposed crescentic glomerulonephritis. J Am Soc Nephrol 6(6):1541–1546PubMed James SH et al (1995) Acute renal failure in membranous glomerulonephropathy: a result of superimposed crescentic glomerulonephritis. J Am Soc Nephrol 6(6):1541–1546PubMed
24.
go back to reference Hall AM et al (2006) Crescentic transformation of membranous glomerulopathy: a reversible condition. Nephrol Dial Transplant 21(4):1136–1137PubMedCrossRef Hall AM et al (2006) Crescentic transformation of membranous glomerulopathy: a reversible condition. Nephrol Dial Transplant 21(4):1136–1137PubMedCrossRef
25.
go back to reference Chen M, Kallenberg CG, Zhao MH (2009) ANCA-negative pauci-immune crescentic glomerulonephritis. Nat Rev Nephrol 5(6):313–318PubMedCrossRef Chen M, Kallenberg CG, Zhao MH (2009) ANCA-negative pauci-immune crescentic glomerulonephritis. Nat Rev Nephrol 5(6):313–318PubMedCrossRef
26.
go back to reference Xiao H et al (2002) Antineutrophil cytoplasmic autoantibodies specific for myeloperoxidase cause glomerulonephritis and vasculitis in mice. J Clin Invest 110(7):955–963PubMedCentralPubMedCrossRef Xiao H et al (2002) Antineutrophil cytoplasmic autoantibodies specific for myeloperoxidase cause glomerulonephritis and vasculitis in mice. J Clin Invest 110(7):955–963PubMedCentralPubMedCrossRef
27.
go back to reference Kobayashi K, Shibata T, Sugisaki T (1995) Aggravation of rat nephrotoxic serum nephritis by anti-myeloperoxidase antibodies. Kidney Int 47(2):454–463PubMedCrossRef Kobayashi K, Shibata T, Sugisaki T (1995) Aggravation of rat nephrotoxic serum nephritis by anti-myeloperoxidase antibodies. Kidney Int 47(2):454–463PubMedCrossRef
28.
go back to reference Haas M, Eustace JA (2004) Immune complex deposits in ANCA-associated crescentic glomerulonephritis: a study of 126 cases. Kidney Int 65(6):2145–2152PubMedCrossRef Haas M, Eustace JA (2004) Immune complex deposits in ANCA-associated crescentic glomerulonephritis: a study of 126 cases. Kidney Int 65(6):2145–2152PubMedCrossRef
29.
go back to reference Hanamura K et al (2011) Detection of myeloperoxidase in membranous nephropathy-like deposits in patients with anti-neutrophil cytoplasmic antibody-associated glomerulonephritis. Hum Pathol 42(5):649–658PubMedCrossRef Hanamura K et al (2011) Detection of myeloperoxidase in membranous nephropathy-like deposits in patients with anti-neutrophil cytoplasmic antibody-associated glomerulonephritis. Hum Pathol 42(5):649–658PubMedCrossRef
Metadata
Title
Crescentic glomerulonephritis and membranous nephropathy: a rare coexistence
Authors
Olga Balafa
Rigas Kalaitzidis
Georgios Liapis
Sofia Xiromeriti
Fotios Zarzoulas
Georgios Baltatzis
Moses Elisaf
Publication date
01-08-2015
Publisher
Springer Netherlands
Published in
International Urology and Nephrology / Issue 8/2015
Print ISSN: 0301-1623
Electronic ISSN: 1573-2584
DOI
https://doi.org/10.1007/s11255-015-1031-z

Other articles of this Issue 8/2015

International Urology and Nephrology 8/2015 Go to the issue

Urology – Letter to the Editor

Pleomorphic adenoma of spermatic cord

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine